StemRIM (4599.T)
StemRIM, a biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
298.00+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-7.5%
The outlook
StemRIM currently reads as leaning bullish based on mixed vs its moving averages, 60% of the way from its 52-week low to high, avg target +135% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range60% of the way from its 52-week low to high
Price targetAvg target +135% vs current price
Market cap
$18.68B
52-wk high
333.00
52-wk low
246.00
50-day avg
298.28
200-day avg
290.40
Trailing P/E
—